» Articles » PMID: 19543285

Parallel Detection of Antigen-specific T-cell Responses by Multidimensional Encoding of MHC Multimers

Overview
Journal Nat Methods
Date 2009 Jun 23
PMID 19543285
Citations 162
Authors
Affiliations
Soon will be listed here.
Abstract

The use of fluorescently labeled major histocompatibility complex multimers has become an essential technique for analyzing disease- and therapy-induced T-cell immunity. Whereas classical major histocompatibility complex multimer analyses are well-suited for the detection of immune responses to a few epitopes, limitations on human-subject sample size preclude a comprehensive analysis of T-cell immunity. To address this issue, we developed a combinatorial encoding strategy that allows the parallel detection of a multitude of different T-cell populations in a single sample. Detection of T cells from peripheral blood by combinatorial encoding is as efficient as detection with conventionally labeled multimers but results in a substantially increased sensitivity and, most notably, allows comprehensive screens to be performed. We obtained proof of principle for the feasibility of large-scale screening of human material by analysis of human leukocyte antigen A3-restricted T-cell responses to known and potential melanoma-associated antigens in peripheral blood from individuals with melanoma.

Citing Articles

Causal relationships between immune cells, plasma metabolites and lung adenocarcinoma: a two-step, two-sample Mendelian randomization study.

Zhou W, Yan T, Hu Z, Wu J, Zhou Y, Xie L J Cancer. 2024; 15(20):6698-6709.

PMID: 39668823 PMC: 11632987. DOI: 10.7150/jca.102760.


DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation.

Fuchs K, Goransson M, Kester M, Ettienne N, van de Meent M, de Jong R J Immunother Cancer. 2024; 12(12).

PMID: 39653555 PMC: 11629015. DOI: 10.1136/jitc-2024-009564.


Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab.

Alban T, Riaz N, Parthasarathy P, Makarov V, Kendall S, Yoo S Nat Med. 2024; 30(11):3209-3222.

PMID: 39349627 DOI: 10.1038/s41591-024-03240-y.


The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer.

Shapiro J, Corrado M, Perry J, Watts T, Bolotin S Hum Vaccin Immunother. 2024; 20(1):2395679.

PMID: 39205626 PMC: 11364080. DOI: 10.1080/21645515.2024.2395679.


Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.

Fischer F, Mucke J, Werny L, Gerrer K, Mihatsch L, Zehetmaier S Virol J. 2024; 21(1):139.

PMID: 38877590 PMC: 11179387. DOI: 10.1186/s12985-024-02411-0.


References
1.
Kawakami Y, Robbins P, Wang X, Tupesis J, Parkhurst M, Kang X . Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. J Immunol. 1998; 161(12):6985-92. View

2.
van Oijen M, Bins A, Elias S, Sein J, Weder P, de Gast G . On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients. Clin Cancer Res. 2004; 10(14):4754-60. DOI: 10.1158/1078-0432.CCR-04-0260. View

3.
Bakker A, Schumacher T . MHC multimer technology: current status and future prospects. Curr Opin Immunol. 2005; 17(4):428-33. DOI: 10.1016/j.coi.2005.06.008. View

4.
Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop N . Design and use of conditional MHC class I ligands. Nat Med. 2006; 12(2):246-51. DOI: 10.1038/nm1360. View

5.
Appay V, van Lier R, Sallusto F, Roederer M . Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A. 2008; 73(11):975-83. DOI: 10.1002/cyto.a.20643. View